Cargando…
Central blood pressure lowering effect of telmisartan‐rosuvastatin single‐pill combination in hypertensive patients combined with dyslipidemia: A pilot study
This multicenter, phase 4, Prospective Randomized Open, Blinded End‐point (PROBE) study aimed to evaluate safety and efficacy of telmisartan/rosuvastatin single‐pill combination (SPC) therapy on lowering central blood pressure (BP) compared with telmisartan monotherapy in hypertensive patients with...
Autores principales: | Choi, JungMin, Sung, Ki‐Chul, Ihm, Sang‐Hyun, Yoon, Chang‐Hwan, Park, Seung Woo, Park, Sung‐Ha, Kim, Jang‐Young, Kwon, Sung‐Uk, Lee, Hae‐Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678791/ https://www.ncbi.nlm.nih.gov/pubmed/34384001 http://dx.doi.org/10.1111/jch.14345 |
Ejemplares similares
-
Efficacy and safety of co‐administered telmisartan/amlodipine and rosuvastatin in subjects with hypertension and dyslipidemia
por: Jin, Xuan, et al.
Publicado: (2020) -
Randomized, multicenter, parallel, open, phase 4 study to compare the efficacy and safety of rosuvastatin/amlodipine polypill versus atorvastatin/amlodipine polypill in hypertension patient with dyslipidemia
por: Jung, Hae Won, et al.
Publicado: (2023) -
The efficacy and safety of co-administration of fimasartan and rosuvastatin to patients with hypertension and dyslipidemia
por: Rhee, Moo-Yong, et al.
Publicado: (2017) -
Is it Time for Single-Pill Combinations in Dyslipidemia?
por: Schiele, François, et al.
Publicado: (2021) -
Effects of rosuvastatin combined with fasudil therapy on rabbits with dyslipidemia
por: Li, Zhiming, et al.
Publicado: (2015)